logo

Press Releases

Microbial Robotics’ New Genetics Rights Management Product Platform Enters International Markets with Patent Filing

Genetics Rights Management (GeRM™) Enables a New Business Model that Delivers Low Cost, Commodity-Priced Molecular Keys Instead of Shipping Genetically Modified Organisms CINCINNATI, Ohio, USA – November 19, 2014 – Microbial Robotics, a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), announced the publication of its Genetics Rights Management (GeRM™) international patent applicat
Read More

Jason E. Barkeloo Resigns From Advisory Board Role With Tauriga Sciences, Inc.

Cites increasing time requirements and diverging corporate missions CINCINNATI, Ohio, USA – November 07, 2014 (4:00 P.M. EST) – Microbial Robotics LLC, (formerly Bacterial Robotics, LLC), a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), announces its CEO, Jason E. Barkeloo, resigned from his role as Special Advisor to the Board of Directors with Tauriga Sciences, Inc. (OTCQB:TAU
Read More

Microbial Robotics Ends Strategic Alliance With Tauriga Sciences, Inc.

Cites diverging corporate missions CINCINNATI, Ohio, USA – November 07, 2014 (4:00 P.M. EST) – Microbial Robotics (formerly Bacterial Robotics, LLC), a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), announced it is ending the strategic alliance with Tauriga Sciences, Inc. (OTCQB:TAUG) effective immediately. Microbial Robotics’ CEO, Jason E. Barkeloo, stated, “While we are gratef
Read More

Bacterial Robotics Announces Strategic Alliance With Bacmine SL and Formation of Microbial Robotics

Microbial Robotics adds innovation portfolio access to industrial and therapeutic microbiology applications with its strategic partnership with Spain-based Bacmine SL. CINCINNATI, Ohio, USA and MADRID, Spain – October 10, 2014 – Bacterial Robotics, a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), announces its strategic alliance with Spain-based Bacmine SL. In line with its acce
Read More

National Science Foundation Continues Support of Bacterial Robotics’ Non-Surgical Tumor Treatment Product Development

SBIR Phase IB to Continue Development of Cholesteatoma Treatment Building on New Research Discovery CINCINNATI, OH, USA –July 23, 2014 – Bacterial Robotics, a biotechnology firm developing ViruBots™ and BactoBots™, announces receipt of a Small Business Innovation Research (SBIR) Phase IB award from the National Science Foundation (NSF).  The award is effective June 30, 2014. The grant enables continued development of
Read More

Bacterial Robotics Reports Research Findings on Tumor Surgical Product

SBIR Phase I findings toward “A Novel Approach to Cholesteatoma Treatment.” CINCINNATI, OH, USA –July 14, 2014 – Bacterial Robotics, a synthetic life biotechnology firm developing ViruBots™ and BactoBots™, announces research findings from its National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award that concluded 30 June 2014. The grant launched the development of an enhanced bacteriu
Read More

Bacterial Robotics Gains Oncolytic Herpesvirus For Inhibiting Cancerous Tumors

Inhibits Tumor Growth and Vascular Progenitors for Neuroblastoma and Malignant Peripheral Nerve Sheath Tumors CINCINNATI, June 23, 2014 /PRNewswire/ — Bacterial Robotics, a synthetic microbial biotechnology firm, today announced it secured an oncolytic herpes simplex virus (oHSV) from Nationwide Children’s Hospital. The oHSV expresses the human tissue inhibitor metalloproteinases (TIMP3) or firefly lucife
Read More

Francis Kirley Appointed To Bacterial Robotics Business Directorate

Mr. Kirley will advise on business model and systems toward profitability CINCINNATI, OH. – May 05, 2014 – Bacterial Robotics is a biotechnology firm.  The Company uses synthetic biology tools in an evolutionary engineering approach to develop bacterial robots, or BactoBots™.  Today, the Company announced the appointment of Mr. Fran Kirley to its Business Directorate. The Company is developing unique therapeutic Bact
Read More

Timothy P. Cripe, MD, PhD, Appointed To Bacterial Robotics Science Directorate

Dr. Cripe will advise on unique and innovative therapeutic product development CINCINNATI, OH. – May 8, 2014 – Bacterial Robotics is a life science biotechnology firm.  The Company uses synthetic biology tools in an evolutionary engineering approach to develop bacterial robots, or BactoBots™.  Today, the Company announced the appointment of Dr. Tim Cripe to its Scientific Directorate. The Company is developing unique
Read More

Raymond Scalettar, MD, DSc, Appointed To Bacterial Robotics Science Directorate

Dr. Scalettar will advise on unique and innovative therapeutic product development CINCINNATI, OH. – April 21, 2014 – Bacterial Robotics is a life science biotechnology firm.  The Company uses synthetic biology tools in an evolutionary engineering approach to develop bacterial robots, or BactoBots™.  Today, the Company announced the appointment of Dr. Ray Scalettar to its Scientific Directorate. The Company is develo
Read More